BSX
Boston Scientific Corporation
Income statement
| USDLine, in USD | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 21.1B | 20.1B | 16.7B | 14.2B | 12.7B | 11.9B | 9.9B | 10.7B | 9.8B | 9.0B | 9.1B | 8.1B | 7.5B | 7.1B | 7.2B | 7.6B | 7.8B | 8.2B | 8.1B | 8.4B |
Cost of revenue | 6.50B | 6.22B | 5.26B | 4.34B | 3.96B | 3.71B | 3.47B | 3.12B | 2.81B | 2.59B | 3.11B | 2.76B | 2.29B | 2.10B | 2.35B | 2.66B | 2.60B | 2.58B | 2.47B | 2.34B |
| Gross profit | 14.6B | 13.9B | 11.5B | 9.9B | 8.7B | 8.2B | 6.4B | 7.6B | 7.0B | 6.5B | 6.0B | 5.3B | 5.2B | 5.0B | 4.9B | 5.0B | 5.2B | 5.6B | 5.6B | 6.0B |
| 2.16B | 2.05B | 1.62B | 1.41B | 1.32B | 1.20B | 1.14B | 1.17B | 1.11B | 1.00B | 0.92B | 0.88B | 0.82B | 0.86B | 0.89B | 0.90B | 0.94B | 1.04B | 1.01B | 1.09B | |
| 7.10B | 6.89B | 5.98B | 5.19B | 4.52B | 4.36B | 3.79B | 3.94B | 3.57B | 3.29B | 3.10B | 2.87B | 2.90B | 2.67B | 2.54B | 2.49B | 2.58B | 2.64B | 2.59B | 2.91B | |
Other operating expenses | 1.38B | 1.30B | 1.29B | 0.95B | 1.24B | 1.42B | 1.60B | 0.99B | 0.82B | 0.88B | 1.50B | 1.84B | 1.75B | 1.31B | 5.35B | 0.68B | 2.34B | 2.84B | 3.49B | 2.03B |
| Operating income | 3.93B | 3.61B | 2.60B | 2.34B | 1.65B | 1.20B | −80M | 1.52B | 1.51B | 1.29B | 0.45B | −0.28B | −0.30B | 0.12B | −3.87B | 0.90B | −0.66B | −0.89B | −1.51B | −14M |
Non-operating income | −277M | −228M | −321M | −358M | −508M | −123M | 1.0M | −831M | −84M | −352M | −270M | −367M | −208M | −343M | −239M | −262M | −407M | −414M | −526M | −555M |
| Pretax income | 3.66B | 3.39B | 2.28B | 1.99B | 1.14B | 1.08B | −79M | 0.69B | 1.42B | 0.93B | 0.18B | −0.65B | −0.51B | −0.22B | −4.11B | 0.64B | −1.06B | −1.31B | −2.03B | −0.57B |
Taxes | 0.15B | 0.49B | 0.43B | 0.39B | 0.44B | 35M | 3.0M | −4.01B | −0.25B | 0.83B | −0.17B | −0.41B | −0.39B | −0.10B | −39M | 0.20B | 2.0M | −0.28B | 5.0M | −74M |
| Net income | 3.50B | 2.90B | 1.85B | 1.59B | 0.70B | 1.04B | −82M | 4.70B | 1.67B | 0.10B | 0.35B | −0.24B | −0.12B | −0.12B | −4.07B | 0.44B | −1.07B | −1.03B | −2.04B | −0.50B |
| Diluted EPS | 2.36 | 1.94 | 1.25 | 1.07 | 0.45 | 0.69 | −0.08 | 3.33 | 1.19 | 0.08 | 0.25 | −0.18 | −0.09 | −0.09 | −2.89 | 0.29 | −0.70 | −0.68 | −1.36 | −0.33 |
| Diluted shares | — | 1.49B | 1.49B | 1.46B | 1.44B | 1.43B | 1.42B | 1.41B | 1.40B | 1.39B | 1.38B | 1.34B | 1.32B | 1.34B | 1.41B | 1.52B | 1.52B | 1.51B | 1.50B | 1.49B |
| Revenue growth | — | +19.9% | +17.6% | +12.3% | +6.7% | +19.9% | −7.7% | +9.3% | +8.6% | −0.3% | +12.5% | +8.1% | +5.5% | −2.4% | −4.9% | −2.4% | −4.7% | +1.7% | −3.7% | — |
| Gross margin | 69.1% | 69.0% | 68.6% | 69.5% | 68.8% | 68.8% | 65.0% | 71.0% | 71.4% | 71.3% | 65.7% | 65.7% | 69.3% | 70.3% | 67.6% | 65.1% | 66.7% | 68.5% | 69.3% | 72.0% |
| Operating margin | 18.7% | 18.0% | 15.5% | 16.5% | 13.0% | 10.1% | −0.8% | 14.1% | 15.3% | 14.2% | 4.9% | −3.5% | −4.0% | 1.7% | −53.4% | 11.9% | −8.4% | −10.9% | −18.7% | −0.2% |
| Net margin | 16.6% | 14.4% | 11.1% | 11.2% | 5.5% | 8.8% | −0.8% | 43.8% | 17.0% | 1.1% | 3.8% | −3.0% | −1.6% | −1.7% | −56.1% | 5.8% | −13.6% | −12.5% | −25.3% | −5.9% |